MedPath

Nantes University Hospital

Nantes University Hospital logo
🇫🇷France
Ownership
Private
Established
1503-01-01
Employees
10K
Market Cap
-
Website
https://www.chu-nantes.fr

Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells

Not Applicable
Terminated
Conditions
Inherited Arrhythmias and Valvulopathies
Interventions
Other: Skin biopsies
First Posted Date
2012-11-27
Last Posted Date
2014-11-07
Lead Sponsor
Nantes University Hospital
Target Recruit Count
20
Registration Number
NCT01734356
Locations
🇫🇷

Nantes University Hospital, Nantes, France

Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles

Phase 4
Completed
Conditions
Parkinson's Disease
Secondary Behavioural Addiction
Interventions
Other: questionnaires
First Posted Date
2012-11-26
Last Posted Date
2018-02-15
Lead Sponsor
Nantes University Hospital
Target Recruit Count
225
Registration Number
NCT01733199
Locations
🇫🇷

Nantes University Hospital, Nantes, France

ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA

Phase 1
Completed
Conditions
HER2 Negative Breast Carcinoma Expressing CEA
First Posted Date
2012-11-21
Last Posted Date
2018-07-27
Lead Sponsor
Nantes University Hospital
Target Recruit Count
23
Registration Number
NCT01730612
Locations
🇫🇷

Hospital, Nantes, France

🇫🇷

Institut de Cancérologie de l'Ouest, Saint Herblain, France

ImmunoTEP for Patients With Medullary Thyroid Carcinoma.

Phase 1
Completed
Conditions
Medullary Thyroid Carcinoma
Interventions
Drug: • TF2 and 68 Ga-IMP-288
First Posted Date
2012-11-21
Last Posted Date
2022-07-26
Lead Sponsor
Nantes University Hospital
Target Recruit Count
25
Registration Number
NCT01730638
Locations
🇫🇷

Nantes Hospital, Nantes, France

🇫🇷

Angers Hospital, Angers, France

🇫🇷

Institut de Cancérologie de l'ouest, René Gauducheau, Saint-Herblain, France

Clinical Reassessment Versus Procalcitonin in Order to Shorten Antibiotic Duration in Community-acquired Pneumonia

Not Applicable
Completed
Conditions
Community-acquired Pneumonia
Interventions
Other: the clinical reassessment arm
Other: the procalcitonin arm
First Posted Date
2012-11-08
Last Posted Date
2017-05-31
Lead Sponsor
Nantes University Hospital
Target Recruit Count
286
Registration Number
NCT01723644
Locations
🇫🇷

University hospital of Agen, Agen, France

🇫🇷

University Hospital of Grenoble, Grenoble, France

🇫🇷

University Hospital of Rennes, Rennes, France

and more 12 locations

Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis

Not Applicable
Terminated
Conditions
Multiple Sclerosis
Interventions
Device: Trap Myelin Test
First Posted Date
2012-11-08
Last Posted Date
2017-05-16
Lead Sponsor
Nantes University Hospital
Target Recruit Count
189
Registration Number
NCT01723631
Locations
🇫🇷

University Hospital of Strasbourg, Strasbourg, France

🇫🇷

University Hospital of Bordeaux, Bordeaux, France

🇫🇷

Hopital neurologigue Pierre Wertheimer, Bron, France

and more 8 locations

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face

Phase 3
Completed
Conditions
Lentigo Maligna Melanoma (Head or Neck)
Interventions
Drug: Placebo + surgery
First Posted Date
2012-11-02
Last Posted Date
2022-12-06
Lead Sponsor
Nantes University Hospital
Target Recruit Count
259
Registration Number
NCT01720407
Locations
🇫🇷

CHU, Tours, France

🇫🇷

AP-HP Hôpital Ambroise Paré, Boulogne Billancourt, France

🇫🇷

CHRU, Lille, France

and more 10 locations

Protocol TARC-ABPA

Not Applicable
Completed
Conditions
Allergic Broncho-Pulmonary Aspergillosis
Interventions
Other: Study of predictive factors
First Posted Date
2012-10-19
Last Posted Date
2018-04-06
Lead Sponsor
Nantes University Hospital
Target Recruit Count
29
Registration Number
NCT01710930
Locations
🇫🇷

CHU Le Mans, Le Mans, France

🇫🇷

Nantes University Hospital, Nantes, France

Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy. (TORSIV)

Phase 4
Terminated
Conditions
Sedation During Bronchoscopy
Interventions
Drug: I.V Sedation
Drug: sublingual sedation
First Posted Date
2012-10-03
Last Posted Date
2023-11-18
Lead Sponsor
Nantes University Hospital
Target Recruit Count
85
Registration Number
NCT01698892
Locations
🇫🇷

Cavailles, Nantes, France

Multicentric Prospective Study of Genetic and Physiopathology Concerning Dysregulation of Complement During Repeated Fetal Abortions

Completed
Conditions
Fetal Losses
Interventions
Other: blood sample
First Posted Date
2012-09-24
Last Posted Date
2014-10-15
Lead Sponsor
Nantes University Hospital
Target Recruit Count
60
Registration Number
NCT01690858
Locations
🇫🇷

Antoine Beclere Hospital (AP-HP), Clamart, France

🇫🇷

CHU, Nantes, France

© Copyright 2025. All Rights Reserved by MedPath